Skip to main content
. Author manuscript; available in PMC: 2009 Dec 30.
Published in final edited form as: Vaccine. 2008 Dec 30;26(Suppl 8):I40–I45. doi: 10.1016/j.vaccine.2008.11.060

Figure 1.

Figure 1

Survival of wild-type meningococci and their fHbp deletion mutants in human blood. Meningococcal strains MC58 and H44/76 (high fHbp expressers) and NZ98/254 and 4243 (low fHbp expressers) and their fHbp deletion mutants were examined for their ability to survive in whole blood derived from two individual donors. Survival of the wild-type strains and their respective fHbp mutants are shown by the solid and broken lines, respectively. Loss of fHbp on only the high expressers, but not the low expressers, compromised bacterial survival. The data are from Ref. [44].